Literature DB >> 26762488

Alternative splicing within the Wnt signaling pathway: role in cancer development.

B Sumithra1, Urmila Saxena1, Asim Bikas Das2.   

Abstract

BACKGROUND: The Wnt signaling cascade plays a fundamental role in embryonic development, adult tissue regeneration, homeostasis and stem cell maintenance. Abnormal Wnt signaling has been found to be prevalent in various human cancers. Also, a role of Wnt signaling in the regulation of alternative splicing of several cancer-related genes has been established. In addition, accumulating evidence suggests the existence of multiple splice isoforms of Wnt signaling cascade components, including Wnt ligands, receptors, components of the destruction complex and transcription activators/suppressors. The presence of multiple Wnt signaling-related isoforms may affect the functionality of the Wnt pathway, including its deregulation in cancer. As such, specific Wnt pathway isoform components may serve as therapeutic targets or as biomarkers for certain human cancers. Here, we review the role of alternative splicing of Wnt signaling components during the onset and progression of cancer.
CONCLUSIONS: Splice isoforms of components of the Wnt signaling pathway play distinct roles in cancer development. Isoforms of the same component may function in a tissue- and/or cancer-specific manner. Splice isoform expression analyses along with deregulated Wnt signaling pathway analyses may be of help to design efficient diagnostic and therapeutic strategies.

Entities:  

Keywords:  Alternative splicing; Cancer; Isoforms; Proliferation; Splicing factor; Wnt signaling; mRNA; β-catenin

Mesh:

Substances:

Year:  2016        PMID: 26762488     DOI: 10.1007/s13402-015-0266-0

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  150 in total

Review 1.  Towards an integrated view of Wnt signaling in development.

Authors:  Renée van Amerongen; Roel Nusse
Journal:  Development       Date:  2009-10       Impact factor: 6.868

Review 2.  The links between axin and carcinogenesis.

Authors:  S Salahshor; J R Woodgett
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

3.  AU-rich elements and alternative splicing in the beta-catenin 3'UTR can influence the human beta-catenin mRNA stability.

Authors:  Andrea Thiele; Yoshikuni Nagamine; Sunna Hauschildt; Hans Clevers
Journal:  Exp Cell Res       Date:  2006-04-15       Impact factor: 3.905

Review 4.  The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.

Authors:  Taj D King; Mark J Suto; Yonghe Li
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

5.  Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.

Authors:  Vânia Gonçalves; Paulo Matos; Peter Jordan
Journal:  Hum Mol Genet       Date:  2009-07-13       Impact factor: 6.150

6.  Genomic organization of the human beta-catenin gene (CTNNB1).

Authors:  F Nollet; G Berx; F Molemans; F van Roy
Journal:  Genomics       Date:  1996-03-15       Impact factor: 5.736

Review 7.  Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene.

Authors:  Koji Aoki; Makoto M Taketo
Journal:  J Cell Sci       Date:  2007-10-01       Impact factor: 5.285

Review 8.  Regulation of gene transcription by mitogen-activated protein kinase signaling pathways.

Authors:  Alan J Whitmarsh
Journal:  Biochim Biophys Acta       Date:  2006-11-17

9.  The Groucho/TLE/Grg family of transcriptional co-repressors.

Authors:  Barbara H Jennings; David Ish-Horowicz
Journal:  Genome Biol       Date:  2008-01-31       Impact factor: 13.583

10.  Novel roles for MLH3 deficiency and TLE6-like amplification in DNA mismatch repair-deficient gastrointestinal tumorigenesis and progression.

Authors:  Peng-Chieh Chen; Mari Kuraguchi; John Velasquez; Yuxun Wang; Kan Yang; Robert Edwards; Dan Gillen; Winfried Edelmann; Raju Kucherlapati; Steven M Lipkin
Journal:  PLoS Genet       Date:  2008-06-13       Impact factor: 5.917

View more
  12 in total

Review 1.  The emerging role of lncRNAs in the regulation of cancer stem cells.

Authors:  Rosario Castro-Oropeza; Jorge Melendez-Zajgla; Vilma Maldonado; Karla Vazquez-Santillan
Journal:  Cell Oncol (Dordr)       Date:  2018-09-14       Impact factor: 6.730

2.  Role of miR-214 in regulation of β-catenin and the malignant phenotype of melanoma.

Authors:  Kirthana Prabhakar; Carlos I Rodrίguez; Ashika S Jayanthy; Dareen M Mikheil; Aishwarya Iyer Bhasker; Ranjan J Perera; Vijayasaradhi Setaluri
Journal:  Mol Carcinog       Date:  2019-07-24       Impact factor: 4.784

Review 3.  Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics.

Authors:  Qiu Peng; Yujuan Zhou; Linda Oyang; Nayiyuan Wu; Yanyan Tang; Min Su; Xia Luo; Ying Wang; Xiaowu Sheng; Jian Ma; Qianjin Liao
Journal:  Mol Ther       Date:  2021-11-15       Impact factor: 11.454

Review 4.  Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer.

Authors:  Antonieta Chavez-Gonzalez; Babak Bakhshinejad; Katayoon Pakravan; Monica L Guzman; Sadegh Babashah
Journal:  Cell Oncol (Dordr)       Date:  2016-09-27       Impact factor: 6.730

5.  Genetics of personalized medicine: cancer and rare diseases.

Authors:  Inês Teles Siefers Alves; Manuel Condinho; Sónia Custódio; Bruna F Pereira; Rafael Fernandes; Vânia Gonçalves; Paulo J da Costa; Rafaela Lacerda; Ana Rita Marques; Patrícia Martins-Dias; Gonçalo R Nogueira; Ana Rita Neves; Patrícia Pinho; Raquel Rodrigues; Eva Rolo; Joana Silva; André Travessa; Rosário Pinto Leite; Ana Sousa; Luísa Romão
Journal:  Cell Oncol (Dordr)       Date:  2018-04-09       Impact factor: 6.730

6.  Inactivation of CYLD in intestinal epithelial cells exacerbates colitis-associated colorectal carcinogenesis - a short report.

Authors:  Demetrios N Karatzas; Konstantinos Xanthopoulos; Panorea Kotantaki; Athanasios Pseftogas; Konstantinos Teliousis; Eudoxia G Hatzivassiliou; Dimitris L Kontoyiannis; Theofilos Poutahidis; George Mosialos
Journal:  Cell Oncol (Dordr)       Date:  2016-04-04       Impact factor: 6.730

7.  Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma.

Authors:  Xuan Sun; Robert C G Martin; Qianqian Zheng; Russell Farmer; Harshul Pandit; Xuanyi Li; Kevin Jacob; Jian Suo; Yan Li
Journal:  Cell Oncol (Dordr)       Date:  2018-08-16       Impact factor: 6.730

8.  Alternative splicing of the Wnt trafficking protein, Wntless and its effects on protein-protein interactions.

Authors:  Jessica Petko; Mathura Thileepan; Molly Sargen; Victor Canfield; Robert Levenson
Journal:  BMC Mol Cell Biol       Date:  2019-07-08

9.  Adipose-Derived Stem Cells Inhibited the Proliferation of Bladder Tumor Cells by S Phase Arrest and Wnt/β-Catenin Pathway.

Authors:  Tao Wang; Xi Yu; Jian Lin; Cong Qin; Tao Bai; Tao Xu; Lei Wang; Xiuheng Liu; Shenglan Li
Journal:  Cell Reprogram       Date:  2019-12       Impact factor: 1.987

Review 10.  WNT Signaling in Disease.

Authors:  Li Fang Ng; Prameet Kaur; Nawat Bunnag; Jahnavi Suresh; Isabelle Chiao Han Sung; Qian Hui Tan; Jan Gruber; Nicholas S Tolwinski
Journal:  Cells       Date:  2019-08-03       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.